You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Pharmacoeconomics Research Unit

The Pharmacoeconomics Research Unit helps policy-makers make better decisions about cancer treatments in Ontario. The healthcare system has finite resources. We help ensure these resources are used efficiently by:

  • conducting pharmacoeconomic analyses
  • helping others interpret existing economic evidence to assess the value of new treatments or interventions
  • working on methods and tools to make health economics more useful to decision-makers

 

The unit also co-founded the Canadian Centre for Applied Research in Cancer Control, a network funded by the Canadian Cancer Society, in partnership with the BC Cancer Agency.

 

Purpose

  • Support the following programs and committees in evaluating and using economic evidence and principles for decision-making:
    • Provincial Drug Reimbursement Programs (PDRP)
    • Ontario Public Drug Programs (OPDP)
    • Ontario Steering Committee for Cancer Drugs (OSCCD)
    • pan-Canadian Oncology Drug Review (pCODR)
  • Strengthen healthcare system accountability by providing evidence of value for money spent on cancer drugs in achieving high-quality patient outcomes
  • Provide technical guidance on health economics and health services research in cancer control to support evidence-based decisions about health policy and practice
  • Illustrate how research can be used to help make decisions about cancer prevention, screening, treatment and end-of-life care

 

Program Initiatives

  • Conduct, evaluate and explain pharmacoeconomic analysis of cancer drugs under review for funding consideration
  • Study the real-world use, effectiveness and cost-effectiveness of cancer drugs that are actively covered by Ontario public drug programs
  • Disseminate findings from cost-effectiveness and costing research through academic conferences and journal publications
  • Contribute to methods and policy research in cancer, economics and health technology assessment

 

Email Unit

If you have questions or comments, email the Pharmacoeconomics Research Unit.